Antiviral Drugs for Hepatitis C (Glecaprevir/Pibrentasvir)
We are seeking regular supplies of oral antiviral medications for treating Hepatitis C with Glecaprevir and Pibrentasvir. This treatment aims to provide care for patients within approved indications.
CONTRACTING AUTHORITY
Name
Institut klinické a experimentální medicíny
City
Praha
Country
CZ
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33651400, Antivirals for systemic use.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
24 days remaining(LOT-0001)
Published